Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2 | Demyelinating Disorders | JN Learning | AMA Ed Hub [Skip to Content]
[Skip to Content Landing]

Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2

Educational Objective
To identify the key insights or developments described in this article
1 Credit CME

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Accepted for Publication: August 5, 2021.

Published Online: September 1, 2021. doi:10.1001/jamaneurol.2021.3287

Corresponding Author: Shirley Shapiro Ben David, MD, Maccabi Healthcare Services, Hamered 27, Tel Aviv 6812509, Israel (shirley.shap@gmail.com).

Author Contributions: Dr Shapiro Ben David had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Shapiro Ben David.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: All authors.

Critical revision of the manuscript for important intellectual content: Rahamim-Cohen.

Supervision: Rahamim-Cohen.

Conflict of Interest Disclosures: None reported.

References
1.
Israeli Ministry of Health. Coronavirus (COVID-19) vaccines. Accessed April 30, 2021. https://www.health.gov.il/UnitsOffice/HD/PH/epidemiology/td/docs/365_Corona.pdff.
2.
Centers for Disease Control and Prevention. COVID-19 vaccines for people with underlying medical conditions. Accessed April 27, 2021. https://www.cdc.gov/coronavirus/2019-ancov/vaccines/recommendations/underlying-conditions.html.
3.
Vellozzi  C , Iqbal  S , Broder  K .  Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.   Clin Infect Dis. 2014;58(8):1149-1155. doi:10.1093/cid/ciu005PubMedGoogle ScholarCrossref
4.
Martín Arias  LH , Sanz  R , Sáinz  M , Treceño  C , Carvajal  A .  Guillain-Barré syndrome and influenza vaccines: a meta-analysis.   Vaccine. 2015;33(31):3773-3778. doi:10.1016/j.vaccine.2015.05.013PubMedGoogle ScholarCrossref
5.
Lunn  MP , Cornblath  DR , Jacobs  BC ,  et al.  COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations.   Brain. 2021;144(2):357-360. doi:10.1093/brain/awaa444PubMedGoogle ScholarCrossref
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
If you are not a JN Learning subscriber, you can either:
Subscribe to JN Learning for one year
Buy this activity
jn-learning_Modal_Multimedia_LoginSubscribe_Purchase
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
Close
With a personal account, you can:
  • Track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
jn-learning_Modal_SaveSearch_NoAccess_Purchase
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close